The study that has found how fluctuations of estrogen make fluctuations on levels of the protein calcitonin gene-related peptide (CGRP) that plays a big part in migraine, involved three groups of female participants with episodic migraine. All had at least three days with migraine in the month before the study. The groups were those with a regular menstrual cycle, those taking oral contraceptives, and those who had gone through menopause. Each group was compared to a group of female participants of similar ages who did not have migraine.
Researchers collected blood and tear fluid to determine CGRP levels. In those with regular menstrual cycles, the samples were taken during menstruation when estrogen levels are low and around the time of ovulation, when levels are the highest. In those taking oral contraceptives, samples were taken during the hormone-free time and the hormone-intake time.
The study found that female participants with migraine and a regular menstrual cycle had higher CGRP concentrations during menstruation than those without migraine.
In contrast, female participants taking oral contraceptives and in postmenopause had similar CGRP levels in the migraine and non-migraine groups.
“The study also suggests that measuring CGRP levels through tear fluid is feasible and warrants further investigation, as accurate measurement in the blood is challenging due to its very short half-life,” Raffaelli said. “This method is still exploratory, but it is non-invasive.”
“This elevated level of CGRP following hormonal fluctuations could help to explain why migraine attacks are more likely during menstruation and why migraine attacks gradually decline after menopause,” said study author Bianca Raffaelli, MD, “These results need to be confirmed with larger studies, but we’re hopeful that they will help us better understand the migraine process.”
Sources:
Bianca Raffaelli, Elisabeth Storch, Lucas Hendrik Overeem, Maria Terhart, Mira Pauline Fitzek, Kristin Sophie Lange, Uwe Reuter. Sex Hormones and Calcitonin Gene–Related Peptide in Women With Migraine: A Cross-sectional, Matched Cohort Study. Neurology, 2023; 10.1212/WNL.0000000000207114 DOI: 10.1212/WNL.0000000000207114
American Academy of Neurology. “Migraines during menstruation: Low estrogen levels paired with higher CGRP levels may jump start migraine.” ScienceDaily. ScienceDaily, 22 February 2023. <www.sciencedaily.com/releases/2023/02/230222210526.htm>.
Images from:
Photo by Natracare
https://unsplash.com/photos/MvFWS7v7noc